Ann: S&P DJ Indices Announces March Quarterly Rebalance, page-66

I understood they did appoint someone to vet communications, because earlier ones were always associated with spelling and grammatical errors and even wrong year on dates etc, as if senior management are all dyslexic. The standard of literacy has notably improved, but I agree that the casual approach to forward forecasting, via lack of clarity over the financial period, which currency, revenue or profit, predictions of imminent licensing that dont eventuate, making sensitive announcements via facebook or shareholder email but not formally on ASX, has probably by itself taken 20c off the current share price and led to ASX300 removal (presumably until Next March).

They keep saying margins are good, but by now I would have expected higher revenues, and so does the market. It seems the value add of their chemicals is not as great as I had hoped, so while they get 40% margin it has so far been 40% of diddeley squat. On the other hand, they are building repeat customer relationships and its early on in what should be an exponential curve of revenue growth. If Moelis are right on revenues and profits, it will be 2019 before the P/E can really justify the MC. We are all anticipating the risk is to the upside on revenues, but it would be nice to see it actually happening faster. A new CEO would normally start by writing off everything possible and setting modest expectations, but thats not likely here, so lets hope a spate of big new news is coincident with his appointment and the NASDAQ listing.